Related Experiment Video
Updated: Aug 15, 2026
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
Published on: April 2, 2013
Development and characterization of a molecular viability assay for Pneumocystis carinii f sp hominis
N H Maher1, S H Vermund, D A Welsh
1Department of Environmental Health Sciences, University of Alabama at Birmingham, Birmingham, AL 35294-2170, USA.
Abstract:
Pneumocystis carinii pneumonia (PCP) remains the most common opportunistic infection among human immunodeficiency virus-infected persons. Despite this, little is known concerning the transmission dynamics of this infection. In the absence of a reliable method to isolate and culture P. carinii from environmental samples, it has not been possible to assess the importance of person-to-person transmission in the epidemiology of PCP. A molecular viability assay was developed for the human form of P. carinii (P. carinii f sp hominis) that is applicable to both clinical specimens and environmental samples. This assay will enable the evaluation of the spread and persistence of viable human P. carinii in the environment.
Insights
Pneumocystis pneumonia (PCP) transmission is poorly understood. A new molecular viability assay for Pneumocystis carinii allows assessment of its spread and persistence in the environment.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Molecular Diagnostics
Background:
- Pneumocystis carinii pneumonia (PCP) is a leading opportunistic infection in individuals with human immunodeficiency virus.
- The transmission dynamics of PCP remain largely unknown due to limitations in detecting viable Pneumocystis carinii in environmental samples.
Purpose of the Study:
- To develop a molecular viability assay for Pneumocystis carinii f sp hominis.
- To enable the assessment of Pneumocystis carinii transmission dynamics in both clinical and environmental settings.
Main Methods:
- Development of a novel molecular viability assay.
- Application of the assay to clinical specimens and environmental samples.
Main Results:
- A reliable molecular viability assay for Pneumocystis carinii f sp hominis was successfully developed.
- The assay is applicable to both clinical and environmental samples, overcoming previous detection limitations.
Conclusions:
- The developed assay provides a crucial tool for investigating the epidemiology of PCP.
- This advancement will facilitate the evaluation of the spread and persistence of viable Pneumocystis carinii in the environment, informing transmission dynamics.
